Anzeige Anzeige: ID Berlin GmbH ×

Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals myDRG Stellenmarkt Gesundheitswesen

« Charité verschiebt wegen Corona erneut Eingriffe | Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals | Viel Zustimmung für neue Krankenhausplanung in NRW »

 

Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals

Principal-agent theory-based cost and reimbursement structures of isavuconazole treatment in German hospitals (Wiley).

Isavuconazole (ISA) is a frequently used antifungal agent for the treatment of invasive fungal diseases (IFDs). However, hospital reimbursement data for ISA is limited. Objectives The primary objective of this...
- - - - - - - -



erschienen am Samstag, 10.10.2020
Anzeige Anzeige: ID GmbH ×